DNMT3A.md
... ...
@@ -15,7 +15,7 @@ timeline
15 15
16 16
|Entity|Tier|Description |
17 17
|:------:|:----:|-----------------------------------------|
18
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
18
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
19 19
20 20
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
21 21
MARK1.md
... ...
@@ -15,7 +15,7 @@ timeline
15 15
16 16
|Entity|Tier|Description |
17 17
|:------:|:----:|-----------------------------------------|
18
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
18
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
19 19
20 20
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
21 21
RARA.md
... ...
@@ -14,7 +14,7 @@ timeline
14 14
15 15
|Entity|Tier|Description |
16 16
|:------:|:----:|-----------------------------------------|
17
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
17
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
18 18
19 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
20 20
SYK.md
... ...
@@ -14,7 +14,7 @@ timeline
14 14
15 15
|Entity|Tier|Description |
16 16
|:------:|:----:|-----------------------------------------|
17
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
17
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
18 18
19 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
20 20
WAC.md
... ...
@@ -16,7 +16,7 @@ timeline
16 16
|Entity|Tier|Description |
17 17
|:------:|:----:|-----------------------------------------|
18 18
|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established|
19
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
19
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
20 20
21 21
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
22 22
ZBTB7A.md
... ...
@@ -17,7 +17,7 @@ timeline
17 17
|Entity|Tier|Description |
18 18
|:------:|:----:|-----------------------------------------|
19 19
|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established |
20
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
20
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
21 21
22 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 23